Lea Jessica Albrecht

Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Renáta Váraljai, Lisa Zimmer, Yahya Al-Matary et al. · Nature Cancer · 2023 · 56 citations · Full text

Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

Lea Jessica Albrecht, Anna Höwner, Klaus Griewank et al. · Clinical and Translational Medicine · 2022 · 27 citations · Full text

Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases

Monika Kleinhans, Lea Jessica Albrecht, Sven Benson et al. · Journal of Diabetes Science and Technology · 2023 · 16 citations · Full text

Characterisation and outcome of RAC1 mutated melanoma

Georg Lodde, Philipp Jansen, Rudolf Herbst et al. · European Journal of Cancer · 2023 · 12 citations

Tumor Biology, Medicine, Melanoma +5

Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma

Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover et al. · European Journal of Cancer · 2024 · 11 citations · Full text